Transaction · 0001762951-26-000006

Donoghoe Nicholas

Donoghoe Nicholas, EVP, CB, SO, reported a transaction classified as exercise at AbbVie Inc. involving 32710.000000 shares for an estimated $2584744.20. Reported holdings after the transaction were 107140.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEVP, CB, SO
ABBVAbbVie Inc.
Filing timeAug 18
Trade dateAug 14, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$258.92
Pre-filing
1mo ago -5.7%1w ago -5.0%1d ago -3.1%
Returns since
7d +3.0%30d +3.0%90d +3.0%180d +3.0%1y +3.0%

ABBV price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ABBV since 2026-08-18Filed 16 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001762951-26-000006
Common Stock, $0.01 par value
Transaction date
Aug 14, 2026
Filed Aug 18, 2026, 09:00 PM · 4d delay
Shares
32.7k sh
$7.90k per share
Estimated value
$258M
Computed from shares × price
Holdings after
107k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, CHIEF BUS/STRAT OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual…

Original filing · 0001762951-26-000006
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ABBV